UK advises under-30s to use alternative to AstraZeneca
UK advises under-30s to use alternative to AstraZeneca
Britain's vaccine advisory committee said adults under age 30 should be offered an alternative to AstraZeneca's COVID-19 vaccine where possible, due to a very rare side effect of blood clots in the brain.
Britain's vaccine advisory committee said adults under age 30 should be offered an alternative to AstraZeneca's COVID-19 vaccine where possible, due to a very rare side effect of blood clots in the brain.